2023-09-24 20:13:04 | Current | ESPI | 14/2023
Legal basis
Article 17 (1) MAR – confidential information.
Contents of the report:
The Management Board of Mycodern SA, based in Gdansk, Poland, “the Company”, informs that today it has entered into discussions with an Investor regarding its investment in the Company. Decisions as to the form, type and amount of the investment will be agreed by the parties through ongoing discussions at this stage no amounts or binding dates for the Investor’s investment in the Company have been specified.
At the same time, the Management Board points out that any decisions regarding the Investor’s investment in the Company, or by other entities also showing interest in investing in the Company, will depend on the receipt of binding offers currently no binding offer has been submitted, nor have other binding talks been initiated_. Any decisions, if any, will be made by the Board of Directors guided by the needs of the Company and the Capital Group it is creating, as well as the possibilities of its development, choosing the option that is most favorable to the Company and its shareholders.
The Management Board considered the above information important due to the fact that the implementation of investments in the Company, may affect its financial results as a consequence of the development of its business. The Management Board will inform of any decisions taken in accordance with the procedure provided by the relevant legal regulations.
- Bartosz Groth- President of the Management Board
2023. Mycodern S.A.